Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kirstgen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Molecular Biosciences|June 3, 2021
Substrate Specificities and Inhibition Pattern of the Solute Carrier Family 10 Members NTCP, ASBT and SOATGary Grosser, Simon Franz Müller, Michael Kirstgen, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 11, 2020
Long-term <i>trans</i>-inhibition of the hepatitis B and D virus receptor NTCP by taurolithocholic acidKira A A T Lowjaga, Michael Kirstgen, Simon F Müller, et al.
Viruses|April 30, 2021
Hepatitis D Virus Entry Inhibitors Based on Repurposing Intestinal Bile Acid Reabsorption InhibitorsMichael Kirstgen, Kira Alessandra Alicia Theresa Lowjaga, Simon Franz Müller, et al.
Scientific Reports|December 11, 2020
Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoidsMichael Kirstgen, Kira Alessandra Alicia Theresa Lowjaga, Simon Franz Müller, et al.
Molecular Nutrition & Food Research|November 26, 2021
Organic Cation Transporter I and Na<sup>+</sup> /taurocholate Co-Transporting Polypeptide are Involved in Retrorsine- and Senecionine-Induced Hepatotoxicity in HepaRG cellsAnne-Margarethe Enge, Florian Kaltner, Christoph Gottschalk, et al.
Viruses|August 28, 2021
Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual ScreeningMichael Kirstgen, Simon Franz Müller, Kira Alessandra Alicia Theresa Lowjaga, et al.
Viruses|April 23, 2022
IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and InfectionMassimo Palatini, Simon Franz Müller, Michael Kirstgen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Molecular Biosciences|June 3, 2021
Substrate Specificities and Inhibition Pattern of the Solute Carrier Family 10 Members NTCP, ASBT and SOATGary Grosser, Simon Franz Müller, Michael Kirstgen, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 11, 2020
Long-term <i>trans</i>-inhibition of the hepatitis B and D virus receptor NTCP by taurolithocholic acidKira A A T Lowjaga, Michael Kirstgen, Simon F Müller, et al.
Viruses|April 30, 2021
Hepatitis D Virus Entry Inhibitors Based on Repurposing Intestinal Bile Acid Reabsorption InhibitorsMichael Kirstgen, Kira Alessandra Alicia Theresa Lowjaga, Simon Franz Müller, et al.
Scientific Reports|December 11, 2020
Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoidsMichael Kirstgen, Kira Alessandra Alicia Theresa Lowjaga, Simon Franz Müller, et al.
Molecular Nutrition & Food Research|November 26, 2021
Organic Cation Transporter I and Na<sup>+</sup> /taurocholate Co-Transporting Polypeptide are Involved in Retrorsine- and Senecionine-Induced Hepatotoxicity in HepaRG cellsAnne-Margarethe Enge, Florian Kaltner, Christoph Gottschalk, et al.
Viruses|August 28, 2021
Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual ScreeningMichael Kirstgen, Simon Franz Müller, Kira Alessandra Alicia Theresa Lowjaga, et al.
Viruses|April 23, 2022
IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and InfectionMassimo Palatini, Simon Franz Müller, Michael Kirstgen, et al.
Pageof 1